UPLOAD Filing
Ensysce Biosciences, Inc.
Date: May 9, 2025 · CIK: 0001716947 · Accession: 0000000000-25-004964
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-286943
Letter
Re: Ensysce Biosciences, Inc. Registration Statement on Form S-3 Filed May 2, 2025 File No. 333-286943 Dear Lynn Kirkpatrick:
May 9, 2025
Lynn Kirkpatrick Chief Executive Officer Ensysce Biosciences, Inc. 7946 Ivanhoe Avenue, Suite 201 La Jolla, CA 92037
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Lauren Hamill at 303-844-1008 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Gregory Rubis
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> May 9, 2025 Lynn Kirkpatrick Chief Executive Officer Ensysce Biosciences, Inc. 7946 Ivanhoe Avenue, Suite 201 La Jolla, CA 92037 Re: Ensysce Biosciences, Inc. Registration Statement on Form S-3 Filed May 2, 2025 File No. 333-286943 Dear Lynn Kirkpatrick: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Lauren Hamill at 303-844-1008 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Gregory Rubis </TEXT> </DOCUMENT>